This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dobrucki, L. W. Articles by Malinski, T. Search for Related Content PubMed PubMed Citation Articles by Dobrucki, L. W. Articles by Malinski, T. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood Pressure Medicines Hazardous Substances DB CLONIDINE NITRIC OXIDE Related Collections Cardiovascular Pharmacology Cell signalling/signal transduction Autonomic, reflex, and neurohumoral control of circulation Receptor pharmacology

(Circulation. 2001;104:1884.)
© 2001 American Heart Association, Inc.

Brief Rapid Communications

Central Hypotensive Action of Clonidine Requires Nitric Oxide

Lawrence W. Dobrucki, MS; Camilo L. Cabrera, MD; David F. Bohr, MD; Tadeusz Malinski, PhD

From the Department of Chemistry and Biochemistry, Ohio University, Athens (L.W.D., T.M.), and the Department of Physiology, University of Michigan, Ann Arbor (C.L.C., D.F.B.).

Correspondence to David F. Bohr, 7714 Med Sci II, Department of Physiology, University of Michigan, Ann Arbor, MI 48109-0622. E-mail bohr{at}umich.edu

Background— Clonidine has an antihypertensive effect by its action in the brain and, because we observed that the tonic production of nitric oxide (NO) in the brain is required to maintain blood pressure at its low, normotensive level, the current study was designed to determine whether the hypotensive action of clonidine resulted from its stimulation of excess NO in the brain.

Methods and Results— Porphyritic microsensors were used to quantify NO concentration in the nucleus tractus solitarius (NTS) in vitro in brain slices and in vivo in the anesthetized rat. In both preparations, the basal production of NO in the NTS was 15±3 nmol/L. In vitro stimulation of the NTS with clonidine (50 nmol/L) resulted in an increase in the NO concentration to 84±7 nmol/L. In vivo, the intracerebroventricular (ICV) infusion of clonidine (0.03 µg) caused an increase in NO concentration in the NTS to 128±17 nmol/L. This ICV injection of clonidine caused a fall in mean arterial pressure of -22±1 mm Hg and a decrease of heart rate of -18±2%. The blockade of NO production with N^G-nitro-L-arginine-methyl ester (2 µmol; delivered ICV, 30 minutes before the clonidine) reduced responses to clonidine for both mean arterial pressure and heart rate (-3±1 mm Hg and -2±1% change, respectively).

Conclusion— The stimulation of the release of NO in the brain by clonidine contributes to its central antihypertensive action.

Key Words: nitric oxide • brain • hypertension • clonidine • solitary nucleus

This article has been cited by other articles:

				J. Peng, Y.-K. Wang, L.-G. Wang, W.-J. Yuan, D.-F. Su, X. Ni, X.-M. Deng, and W.-Z. Wang Sympathoinhibitory mechanism of moxonidine: role of the inducible nitric oxide synthase in the rostral ventrolateral medulla Cardiovasc Res, July 4, 2009; (2009) cvp202v2. [Abstract] [Full Text] [PDF]

				J. A. Joles and H. A. Koomans Causes and Consequences of Increased Sympathetic Activity in Renal Disease Hypertension, April 1, 2004; 43(4): 699 - 706. [Abstract] [Full Text] [PDF]